[Prevention of thrombosis during therapy of gynecologic neoplasms].
Blood coagulation, but especially diagnosis, prophylaxis and therapy of thromboembolic complications are of special importance in gynaecology. Besides connatal factors acquired factors are to be considered. Carcinomas enhance hypercoagulation, especially if x-ray treatment is performed. There exists a great number of diagnostic and therapeutic possibilities, though adequate prophylaxis is much more efficient than extensive diagnosis. Among the many possibilities of prophylaxis of thromboembolic complications the subcutaneous application of heparin in subclinical doses is especially efficient. Application is simple, paractically painless, additionally healing is enhanced by heparin.
D003374:Coumarins / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D005260:Female; D005780:Gelatin / Q000627:therapeutic use; D005833:Genital Neoplasms, Female / Q000532:radiotherapy*; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D010974:Platelet Aggregation / Q000187:drug effects; D013213:Starch / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control*
D003374:Coumarins; D003911:Dextrans; D005780:Gelatin; D013213:Starch; D006493:Heparin
Thrombose-Prophylaxe bei der Therapie gynäkologischer Karzinome.